AstraZeneca announces new phase III clinical data for baxdrostat
AstraZeneca announced new Phase III clinical data for baxdrostat, an investigational, first-in-class, oral aldosterone synthase…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AstraZeneca
AstraZeneca strengthens COPD treatment pathways
AstraZeneca India, a science-led biopharmaceutical company, is advancing its commitment to chronic respiratory care by extending…
Cell therapy’s next chapter: Industry embraces in-vivo innovation
Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that Cell therapy is entering a bold new phase…
AstraZeneca India launches Eculizumab to treat aHUS and PNH
AstraZeneca India, a leading global biopharmaceutical company has launched Eculizumab concentrate solution for infusion (300 mg,10…
Symbiosis completes 1,000th batch of injectable drug product
Symbiosis played a pivotal role in the clinical development of the Oxford University/AstraZeneca COVID-19 vaccine
Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData
Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024
India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025
GlobalData’s latest report reveals that Iran’s clinical trials have been affected, with 348 trials initiated in Q2, compared to…
GlobalData forecasts ADC NSCLC market to reach $3.9 bn in 2032
GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD:…
GlobalData’s latest analysis reveals that tezepelumab, evaluated in the Phase IIa COURSE trial, achieved a 26 per cent reduction…
ICON retains lead as most active CRO in Q1 2025, reveals GlobalData
GlobalData’s Q1 2025 report highlights ICON’s continued CRO dominance, Russia’s clinical trial volume lead in Europe, and…